STOCK TITAN

Nano Nuclear (NNE) CEO logs 200K option exercise, holds 685K shares

(Neutral)
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Nano Nuclear Energy Inc. (NNE) director and Chief Executive Officer James John Walker reported an amended Form 4 reflecting the exercise of 200,000 stock options at an exercise price of $3.00 per share into 200,000 shares of common stock on June 3, 2026. Following this option exercise, the amended tables show 780,000 shares of common stock beneficially owned and 300,000 options held immediately after the transaction, with the options originally granted on March 13, 2025 and expiring March 13, 2035. A footnote further clarifies that, as of the date of the report, Walker holds 685,000 shares of common stock and 300,000 options, and notes that this amendment corrects the original June 5, 2026 Form 4 to properly reflect the exercised options and resulting holdings.

Positive

  • None.

Negative

  • None.
Insider Walker James John
Role Chief Executive Officer
Type Security Shares Price Value
Exercise Stock Options F1, F4, F3 200,000 $0.00 $0.00
Exercise Common Stock F1, F4, F2 200,000 $3.00 $600K
Holdings After Transaction: Stock Options — 300,000 shares (Direct); Common Stock — 780,000 shares (Direct)
Footnotes (4)
  1. F1. Represents shares of common stock issued upon exercise of certain options originally granted to the reporting person at the exercise price of $3.00 per share, which were fully vested and exercisable on June 7, 2023, with expiry on June 7, 2026. On June 3, 2026, such options were exercised.
  2. F2. This number does not reflect subsequent sales of the 123,688 shares of common stock reported in the Form 4 originally filed on June 5, 2026.
  3. F3. Represents options granted on March 13, 2025 ("Grant Date") under the Issuer's 2023 Stock Option Plan #2 to purchase an aggregate of 300,000 shares of common stock, par value $0.0001 per share of the Issuer. The options shall vest and become exercisable on the Grant Date immediately. The options are valid for 10 years from the Grant Date and will expire on March 13, 2035.
  4. F4. This Form 4/A is being filed solely to amend the Form 4 originally filed by the reporting person on June 5, 2026 to reflect (i) the 200,000 shares of common stock acquired by such reporting person upon exercise of 200,000 options and 780,000 shares of common stock beneficially owned following such option exercise under Columns 3, 4, and 5 of Table I; and (ii) the 200,000 options exercised by such reporting person and the 300,000 options owned following such option exercise under Columns 5,7 and 9 of Table II. As of the date of this report, the reporting person holds 685,000 shares of common stock, and 300,000 options, of the Issuer, respectively.
Options exercised 200,000 stock options Exercised on June 3, 2026 at an exercise price of $3.00 per share
Exercise price $3.00 per share Exercise price of options converted into 200,000 shares of common stock
Shares beneficially owned after exercise (table figure) 780,000 shares of common stock Beneficially owned immediately following the June 3, 2026 option exercise
Current common shares held as of report date 685,000 shares of common stock Holdings as of the date of the amended report, per footnote
Options held after exercise 300,000 options Options remaining after the June 3, 2026 exercise under the 2023 Stock Option Plan #2
Prior sale referenced 123,688 shares of common stock Subsequent sales reported in the original Form 4 filed June 5, 2026
Option term 10 years Options granted March 13, 2025 expire on March 13, 2035
beneficially owned financial
"780,000 shares of common stock beneficially owned following such option exercise"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
stock options financial
"Represents shares of common stock issued upon exercise of certain options"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"originally granted to the reporting person at the exercise price of $3.00 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Form 4/A regulatory
"This Form 4/A is being filed solely to amend the Form 4"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.
2023 Stock Option Plan #2 financial
"under the Issuer's 2023 Stock Option Plan #2 to purchase an aggregate"

FAQ

What insider transaction did NNE CEO James John Walker report on this amended Form 4/A?

He reported exercising 200,000 stock options at an exercise price of $3.00 per share on June 3, 2026, receiving 200,000 shares of Nano Nuclear Energy Inc. common stock as a result of this derivative exercise.

How many NNE common shares did James John Walker beneficially own after the June 3, 2026 option exercise?

Immediately after the June 3, 2026 option exercise, the amended filing shows that James John Walker beneficially owned 780,000 shares of common stock of Nano Nuclear Energy Inc., before giving effect to subsequent sales referenced in a prior Form 4.

What are James John Walker’s current reported holdings in NNE as of the date of this Form 4/A?

A footnote states that, as of the date of this amended report, James John Walker holds 685,000 shares of common stock and 300,000 stock options of Nano Nuclear Energy Inc.

What option grant is referenced in the NNE Form 4/A footnotes for James John Walker?

The filing references options granted on March 13, 2025 under the 2023 Stock Option Plan #2 to purchase an aggregate of 300,000 shares of common stock, which vested immediately and are valid for 10 years, expiring on March 13, 2035.

Why was the Nano Nuclear Energy Inc. Form 4 amended to Form 4/A?

The Form 4/A was filed to amend the original June 5, 2026 Form 4, correcting the reporting of (i) the 200,000 shares acquired upon option exercise and resulting 780,000 shares beneficially owned, and (ii) the 200,000 options exercised and 300,000 options owned afterward.

What prior sales of NNE shares by James John Walker are referenced in this Form 4/A?

A footnote notes that the 780,000-share post-transaction figure does not reflect subsequent sales of 123,688 shares of common stock that were reported in the original Form 4 filed on June 5, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Walker James John

(Last)(First)(Middle)
10 TIMES SQUARE,
30TH FLOOR

(Street)
NEW YORK NEW YORK 10018

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nano Nuclear Energy Inc. [ NNE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
06/05/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026M(1)200,000(1)(4)A$3780,000(2)(4)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options(1)$306/03/2026M200,000(1)(4) (1) (1)Common Stock200,000(1)(4)$0300,000(3)(4)D
Explanation of Responses:
1. Represents shares of common stock issued upon exercise of certain options originally granted to the reporting person at the exercise price of $3.00 per share, which were fully vested and exercisable on June 7, 2023, with expiry on June 7, 2026. On June 3, 2026, such options were exercised.
2. This number does not reflect subsequent sales of the 123,688 shares of common stock reported in the Form 4 originally filed on June 5, 2026.
3. Represents options granted on March 13, 2025 ("Grant Date") under the Issuer's 2023 Stock Option Plan #2 to purchase an aggregate of 300,000 shares of common stock, par value $0.0001 per share of the Issuer. The options shall vest and become exercisable on the Grant Date immediately. The options are valid for 10 years from the Grant Date and will expire on March 13, 2035.
4. This Form 4/A is being filed solely to amend the Form 4 originally filed by the reporting person on June 5, 2026 to reflect (i) the 200,000 shares of common stock acquired by such reporting person upon exercise of 200,000 options and 780,000 shares of common stock beneficially owned following such option exercise under Columns 3, 4, and 5 of Table I; and (ii) the 200,000 options exercised by such reporting person and the 300,000 options owned following such option exercise under Columns 5,7 and 9 of Table II. As of the date of this report, the reporting person holds 685,000 shares of common stock, and 300,000 options, of the Issuer, respectively.
/s/ James John Walker08/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)